CA1148962A - N-substituted aziridine-2-carboxylic acid derivatives - Google Patents

N-substituted aziridine-2-carboxylic acid derivatives

Info

Publication number
CA1148962A
CA1148962A CA000345886A CA345886A CA1148962A CA 1148962 A CA1148962 A CA 1148962A CA 000345886 A CA000345886 A CA 000345886A CA 345886 A CA345886 A CA 345886A CA 1148962 A CA1148962 A CA 1148962A
Authority
CA
Canada
Prior art keywords
cyano
formula
radical
process according
aziridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000345886A
Other languages
English (en)
French (fr)
Inventor
Elmar Bosies
Wolfgang Kampe
Max Thiel
Uwe Bicker
Dietmar Boerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA1148962A publication Critical patent/CA1148962A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA000345886A 1979-02-21 1980-02-18 N-substituted aziridine-2-carboxylic acid derivatives Expired CA1148962A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP2906603.3 1979-02-21
DE19792906603 DE2906603A1 (de) 1979-02-21 1979-02-21 N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
CA1148962A true CA1148962A (en) 1983-06-28

Family

ID=6063481

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000345886A Expired CA1148962A (en) 1979-02-21 1980-02-18 N-substituted aziridine-2-carboxylic acid derivatives

Country Status (19)

Country Link
US (2) US4397848A (OSRAM)
EP (1) EP0014976B1 (OSRAM)
JP (1) JPS55113760A (OSRAM)
AR (1) AR223863A1 (OSRAM)
AT (1) ATE818T1 (OSRAM)
AU (1) AU529982B2 (OSRAM)
CA (1) CA1148962A (OSRAM)
CS (1) CS208798B2 (OSRAM)
DD (1) DD148772A5 (OSRAM)
DE (2) DE2906603A1 (OSRAM)
ES (1) ES488656A1 (OSRAM)
FI (1) FI70702C (OSRAM)
HU (1) HU182801B (OSRAM)
IE (1) IE49267B1 (OSRAM)
IL (1) IL59425A (OSRAM)
PL (1) PL129707B1 (OSRAM)
PT (1) PT70847A (OSRAM)
SU (1) SU1181541A3 (OSRAM)
ZA (1) ZA80902B (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
JPH07301287A (ja) * 1995-03-23 1995-11-14 Sumitomo Heavy Ind Ltd 制御装置に用いられる内接噛合遊星歯車機構
DE69819192T2 (de) 1997-06-27 2004-06-09 Amplimed, Inc., Tucson Neue cyanoaziridine zur behandlung von krebs
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
AU2002216672A1 (en) * 2000-11-21 2002-06-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Composition comprising an imexon or derivatives thereof and lipids
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
ES2295816T3 (es) 2003-01-14 2008-04-16 Arena Pharmaceuticals, Inc. Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
US20070066590A1 (en) * 2003-02-24 2007-03-22 Jones Robert M Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
ATE415397T1 (de) * 2004-06-04 2008-12-15 Arena Pharm Inc Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
DE602006006461D1 (de) * 2005-09-16 2009-06-04 Arena Pharm Inc Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
AU2018220521A1 (en) 2017-02-16 2019-09-05 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
KR102859841B1 (ko) 2018-06-06 2025-09-12 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 병태의 치료 방법
CN113816887A (zh) * 2021-08-31 2021-12-21 华中科技大学 一种氮杂环丙烷类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2731264A1 (de) 1977-07-11 1979-02-01 Boehringer Mannheim Gmbh Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
DD148772A5 (de) 1981-06-10
ZA80902B (en) 1981-03-25
IL59425A (en) 1984-05-31
IE800327L (en) 1980-08-21
DE2906603A1 (de) 1980-09-04
IL59425A0 (en) 1980-05-30
AU529982B2 (en) 1983-06-30
PL129707B1 (en) 1984-06-30
JPH0150700B2 (OSRAM) 1989-10-31
ES488656A1 (es) 1980-09-16
JPS55113760A (en) 1980-09-02
CS208798B2 (en) 1981-09-15
AU5564980A (en) 1980-08-28
SU1181541A3 (ru) 1985-09-23
US4397848A (en) 1983-08-09
AR223863A1 (es) 1981-09-30
ATE818T1 (de) 1982-04-15
FI70702B (fi) 1986-06-26
PT70847A (de) 1980-03-01
US4517183A (en) 1985-05-14
HU182801B (en) 1984-03-28
DE3060268D1 (en) 1982-05-19
EP0014976B1 (de) 1982-04-07
EP0014976A1 (de) 1980-09-03
FI800510A7 (fi) 1980-08-22
IE49267B1 (en) 1985-09-04
PL222088A1 (OSRAM) 1980-12-01
FI70702C (fi) 1986-10-06

Similar Documents

Publication Publication Date Title
CA1148962A (en) N-substituted aziridine-2-carboxylic acid derivatives
US3862139A (en) Heterocyclic benzamide compounds
US3950418A (en) Vitamin A acid amides
US3288795A (en) 1, 4-bis-(diphenylacetyl) piperazines
US4410532A (en) N-Substituted aziridine-2-carboxylic acid derivatives and their immuno-stimulation compositions and methods
EP0350878B1 (en) Conjugated gamma-oxybutenolide compounds for treating ulcer
DE3854981T2 (de) 1-Pyrrolidinacetamid-Derivate und ihre Verwendung
US4158062A (en) Cyclopentane derivatives
JPH0615533B2 (ja) ピラジン誘導体およびこれを含有する血小板凝集抑制剤
US3920691A (en) 5-(3-substituted amino-2-hydroxypropoxy)-1,3-disubstituted pyrazoles and method of preparation
US3968224A (en) 3-(4'-Chlorophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazole, its use as an anti-inflammatory agent
US4478838A (en) 1-(3,4,5-Trimethoxycinnamoyl)-4-alkylaminocarbonylethyl piperazines
EP0047358B1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same
US4393204A (en) 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones
US4464379A (en) Indol acetic acid derivatives and anti-inflamatory and related uses thereof
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
JP2835545B2 (ja) 白内障予防及び治療剤
US4005073A (en) 6-Acyl derivatives of aminopenicillanic acid
SU816402A3 (ru) Способ получени аминопроизводных2-МЕТил-5-(2-ОКСиСТиРил)-1,3,4-ТиА-диАзОлА или иХ СОлЕй
US4185021A (en) 5-(p-Nitrophenyl)-2-furaldehyde 2-(2-hydroxyethyl)hydrazone
US4088774A (en) 2-Phenyl-3-(4-hydroxycoumarin-3-yl)phthalimidine
US3069318A (en) 2-lower alkyl-4, 5-dihydro-3-pyridazinone-6-carboxamides and antitussive compositions
US4341773A (en) 2,4-Diamino-5-sulfamoylbenzene sulfonic acids and process for their manufacture
US4097609A (en) 2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes
CH642072A5 (en) Process for the preparation of aminoalkylfuran derivatives

Legal Events

Date Code Title Description
MKEX Expiry